Xenon Pharmaceuticals (XENE) Change in Receivables (2016 - 2025)
Historic Change in Receivables for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$283000.0.
- Xenon Pharmaceuticals' Change in Receivables fell 44096.39% to -$283000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$116000.0, marking a year-over-year decrease of 13213.3%. This contributed to the annual value of $614000.0 for FY2024, which is 57230.77% up from last year.
- Xenon Pharmaceuticals' Change in Receivables amounted to -$283000.0 in Q3 2025, which was down 44096.39% from -$7.6 million recorded in Q2 2025.
- Xenon Pharmaceuticals' Change in Receivables' 5-year high stood at $7.2 million during Q1 2025, with a 5-year trough of -$7.6 million in Q2 2025.
- Moreover, its 5-year median value for Change in Receivables was -$38000.0 (2024), whereas its average is -$77736.8.
- Within the past 5 years, the most significant YoY rise in Xenon Pharmaceuticals' Change in Receivables was 1898947.37% (2025), while the steepest drop was 3445454.55% (2025).
- Quarter analysis of 5 years shows Xenon Pharmaceuticals' Change in Receivables stood at -$481000.0 in 2021, then tumbled by 214.97% to -$1.5 million in 2022, then soared by 119.41% to $294000.0 in 2023, then surged by 86.05% to $547000.0 in 2024, then plummeted by 151.74% to -$283000.0 in 2025.
- Its last three reported values are -$283000.0 in Q3 2025, -$7.6 million for Q2 2025, and $7.2 million during Q1 2025.